GoingToMeet

D2D covers topics important to three interconnected and diverse fields that make up its conference tracks: Sequencing and Detection Technologies, Molecular Diagnostics, and Biomarkers.

Sequencing and Detection Technologies
» Learn about advances in miRNA prediction, detection, and analysis methods
» Explore Next Generation Sequencing technologies being used in novel applications
» Evaluate various miRNA purification and labeling methods for how they may impact downstream activity and analysis

Molecular Diagnostics
» Learn about companion diagnostics, third world diagnostics, commercialization of microarray-based molecular diagnostics for personalized medicine applications, and biomarker and molecular diagnostic reimbursement
» Hear viewpoints and updates on the regulatory environment important to molecular diagnostic development and success in the clinic

Biomarkers
» Gain scientific knowledge for development of effective patient stratification schema
» Hear about new research into miRNA, imaging, metabolomic, and proteomic biomarkers and how they inform diagnosis of a range of diseases
» Learn how functional RNAi molecules are being translated from markers into therapeutics

SPEAKERS:
-- Isidore Rigoutsos, Ph.D., IBM Thomas J Watson Research Center
-- Scott Patterson, Ph.D., Amgen Inc.
-- Richard Naples, BD, Medical – Pharmaceutical Systems
-- Mahendra Rao, MD, Ph.D., Invitrogen Corporation
-- Dietrich Stephan, Ph.D., Translational Genomics Research Institute
-- Bernhard Palsson, Ph.D., University of California at San Diego
-- David Persing, MD, Ph.D., Cepheid
-- Thomas Cebula, Ph.D., CFSAN, FDA